Using genomic testing to access the suitability of breast cancer patients for chemotherapy | Dr Joseph Gligorov at Annual Meeting 2015

Using genomic testing to access the suitability of breast cancer patients for chemotherapy | Dr Joseph Gligorov at Annual Meeting 2015

User Photo
EMJ

5 years
290 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Joseph Gligorov, MD, PhD, of Sorbonne Université, Paris, France, discusses the use of genomic tests as predictive tools for adjuvant chemotherapy benefit in the management of patients with breast cancer.

This content is supported by Genomic Health, Inc.



European Medical Journal

Website: http://emjreviews.com/
Twitter: https://twitter.com/EMJReviews
Facebook: https://www.facebook.com/emjreviews
Up Next Autoplay